论文部分内容阅读
艾滋病以及对艾滋病的预防和治疗,仍然是一个需全球共同关注的健康问题。本文对近年来国内外已批准上市的整合酶抑制剂拉替拉韦、埃替拉韦、dolutegravir等药物的研究与应用进行综述,以期为临床医生提供新的临床治疗选择。
AIDS and the prevention and treatment of AIDS remain a health issue that requires global attention. This review summarizes the research and application of integrase inhibitors such as raltegravir, eptifibatide and dolutegravir that have been approved to be listed at home and abroad in order to provide clinicians with new clinical treatment options.